Early diagnostic biomarkers of Lung cancer; a review study

Abstract

Lung cancer is the main cause of cancer-related death. Typically, lung cancer has been classified in two histologic types; small and non-small cell (NSC), with adenocarcinoma, squamous cell form and large cell type. The availability of predictive biomarkers for the treatment of NSC lung cancer (NSCLC) has been changed in recent decades, especially in the form of adenocarcinoma. Controlling for sensitizing mutations inside the epidermal growth factor receptor (EGFR) for patients with advanced adenocarcinomas is currently needed before the achievement of anti-EGFR inhibitors (such as erlotinib, gefitinib, afatinib or osimertinib). In a patient with no signs of tumor tissue, the EGFR mutational plasma and urine examination may be performed. ALK gene rearrangement research is required to predict crizotinib reaction. Treatment with ceritinib, alectinib or brigatinib also relies on ALK rearrangements. PD-L1 should be tested with an approved assay to model reactions in patients with advanced adenocarcinoma or squamous cell NSCLCs to the single pembrolizumab agent in their first-line therapy. As miRNAs are a vital biomarker (diagnostic biomarkers), miRNAs also could be used as a dynamic tumor predictor before and during therapy because of their function in carcinogenesis at all stages. Nevertheless, lncRNA sheds fresh insight into our tumor pathway perception. In biomedicine, lncRNA is intensely involved, which can be used for a wide variety of cancers as a clinical diagnostic and prediction predictor.

Authors and Affiliations

Mostafa Khafaei; Ali Miri; Ebrahim Kiani; Elham Danesh; Mehdi Naderi

Keywords

Related Articles

The crucial role of estrogen/androgen hormones and their receptors in male infertility risk

Steroid hormones, including androgen and estrogen, regulate gene transcription in several tissues, especially in reproductive systems. It has been shown that the two these mentioned hormones are vital for the regulation...

Alzheimer's disease as a neurodegenerative disorder and the apolipoprotein E gene as its genetic biomarker

Alzheimer's disease (AD) is a progressive brain disorder that slowly destroys memory and thinking and functional skills. Alzheimer's disease is classified into two familial and sporadic types. Alzheimer's disease is also...

Genetic and epigenetic collaboration in Parkinson’s disease

Parkinson's disease (PD) is a common neurodegenerative syndrome directly related to age development. This pathologic condition presents in many types of forms. Some efforts applied to understand PD development include re...

The moisture determination of bee pollen from Sivas Province in Anatolia and their antiproliferative activities in MCF-7 cell line

Pollen, one of the bee products, is an important nutrient for bees. Pollen is mainly used for feeding adult, old and larval bees to meet their needs for protein, vitamins and minerals. Since the protein content of pollen...

Triple-negative breast cancer: biology, pathology, and treatment

Triple negative breast cancer (TNBC) is a subtype of breast tumor which comprises 24% of newly diagnosed tumors that lacks hormone receptor expression and HER2 gene amplification. This study illustrated the pathological...

Download PDF file
  • EP ID EP714353
  • DOI 10.22034/CAJMPSI.2021.03.02
  • Views 96
  • Downloads 0

How To Cite

Mostafa Khafaei; Ali Miri; Ebrahim Kiani; Elham Danesh; Mehdi Naderi (2021). Early diagnostic biomarkers of Lung cancer; a review study. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation, 1(3), -. https://www.europub.co.uk/articles/-A-714353